Nairobi — The Ministry of Health has rolled out a new ARV first-line drug that can improve and prolong lives of thousands of people living with HIV who suffer severe side effects and resistance to treatment.
The new drug Dolutegravir (DTG), a generic version will first be administered to 27,000 patients in Kenya before being rolled out in Uganda and Nigeria later this year.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article